Table 1 Baseline characteristic of the included patients
| Â | Valid cases, n(%) | Values |
|---|---|---|
Clinical characteristics | ||
 Age, years | 86 (100) | 35.8 ± 13.2 |
 Gender, female | 86 (100) | 59 (68%) |
 BMI, kg/m2 | 86 (100) | 21.2 ± 4.0 |
Laboratory measurements | ||
 Hemoglobin, g/l | 86 (100) | 139.2 ± 22.9 |
 Adiponectin, ug/ml | 86 (100) | 7.9 ± 5.8 |
 NT-proBNP, pg/ml | 72 (84) | 468.6 ± 1011.5 |
 Glucose, mmol/l | 86 (100) | 4.9 ± 1.4 |
 Creatinine, umol/l | 86 (100) | 64.2 ± 15.1 |
 CHOL, mmol/l | 81 (94) | 4.4 ± 0.8 |
 TRIG, mmol/l | 81 (94) | 1.2 ± 0.9 |
 HDLC, mmol/l | 81 (94) | 1.2 ± 0.2 |
 LDLC, mmol/l | 81 (94) | 2.8 ± 0.7 |
 TRIG/HDLC | 81 (94) | 1.1 ± 1.2 |
Echocardiography | ||
 LVEF,% | 86 (100) | 63.6 ± 9.9 |
 LA, mm | 86 (100) | 35.9 ± 7.7 |
 LVEDD, mm | 86 (100) | 44.3 ± 10.1 |
 LVESD, mm | 86 (100) | 27.9 ± 8.3 |
 RA, mm | 86 (100) | 56.8 ± 15.8 |
 RVEDD, mm | 86 (100) | 60.4 ± 10.4 |
 TAPSE, mm | 41 (48) | 21.0 ± 5.4 |
 S′, cm/s | 41 (48) | 13.4 ± 3.9 |
Right heart catheterization | ||
 mRAP, mmHg | 86 (100) | 5.8 ± 2.9 |
 mPAP, mmHg | 86 (100) | 41.7 ± 23.7 |
 PAWP, mmHg | 86 (100) | 9.7 ± 2.9 |
 MOS,% | 86 (100) | 70.0 ± 10.5 |
 PVR, wood units | 86 (100) | 5.7 ± 5.9 |
 PI, L/min/m2 | 86 (100) | 6.8 ± 3.3 |
 CI, L/min/m2 | 86 (100) | 3.7 ± 1.0 |
 QP/QS | 86 (100) | 1.9 ± 0.9 |
 RP/RS | 86 (100) | 0.3 ± 0.3 |